Lifecore gets $5.5M prepayment from Alcon; annual meeting set for Aug 15, 2024

LIFECORE BIOMEDICAL, INC. DE

Alcon Research paid $5.5M prepayment for future product purchases; credits apply in 2026.
Lifecore subsidiary amends contract manufacturing agreement with Alcon, effective May 2, 2024.
Board sets 2023 annual meeting for Aug 15, 2024; shareholder proposals due by May 18, 2024.
Prepayment provides $5.5M near-term liquidity; customer commitment indicator.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

LIFECORE BIOMEDICAL, INC. DE amended Amendment No. 1 with Alcon Research, LLC valued at $5,500,000 (effective 2024-05-02).

Action: amendment
Agreement: supply
Counterparty: Alcon Research, LLC
Value: $5,500,000
Effective: 2024-05-02

Exact text from the filing

On May 2, 2024, Lifecore Biomedical, LLC, a subsidiary of Lifecore Biomedical, Inc. (the “Company”), entered into Amendment No. 1 (the “ARCMA Amendment”) to Amended and Restated Contract Manufacturing Agreement with Alcon Research, LLC (the “ARCMA”), under which Alcon made a prepayment in the amount of $5,500,000 toward future purchases of products under the ARCMA.

View on SEC.gov

292 material agreements filed in the last 30 days. Browse all material agreements →

LIFECORE BIOMEDICAL, INC. DE filing history →

Source: SEC EDGAR

accession 0001005286-24-000059

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.